Legend Biotech (LEGN) Cash from Operations (2019 - 2025)
Legend Biotech (LEGN) reported Cash from Operations of 12200000.0 for Q4 2025, up 85.14% on a YoY basis from 6589605.26 in Q4 2024, and down 142.36% quarter-over-quarter from 28801000.0 in Q3 2025.
Legend Biotech (LEGN) Cash from Operations (2019 - 2025) Analysis & Trends
Legend Biotech has reported Cash from Operations for 7 years, with the latest figure at 12200000.0 in Q4 2025.
- For the quarter ending Q4 2025, Cash from Operations rose 85.14% year-over-year to 12200000.0; the trailing twelve-month figure through Dec 2025 stood at 100195000.0 (up 30.45% YoY), and the FY2025 full-year result was 100200000.0, up 30.42% from the prior year.
- Cash from Operations for Q4 2025 stood at 12200000.0, down from 28801000.0 in the prior quarter.
- The five-year high for Cash from Operations was 28801000.0 in Q3 2025, with the low at 198465000.0 in Q4 2021.
- Historically, Cash from Operations has averaged 58313050.0 across 5 years, with a median of 59228500.0 in 2021.
- Annual changes were most pronounced in 2023 — Cash from Operations slumped 13084.86% — and 2025, when it soared 137.99%.
- Legend Biotech's Cash from Operations stood at 198465000.0 in 2021, then surged by 74.94% to 49742000.0 in 2022, then slumped by 92.28% to 95645000.0 in 2023, then rose by 14.16% to 82100000.0 in 2024, then surged by 85.14% to 12200000.0 in 2025.
- The last three Cash from Operations figures came in at 12200000.0 (Q4 2025), 28801000.0 (Q3 2025), and 13042000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 1.08 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -12.20 Mn |
| Dec 31, 2025 | -12.20 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Sep 30, 2025 | 28.80 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Jun 30, 2025 | -13.04 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Mar 31, 2025 | -103.75 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Dec 31, 2024 | -82.10 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Sep 30, 2024 | -75.82 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Jun 30, 2024 | -1.65 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Mar 31, 2024 | 15.52 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Dec 31, 2023 | -95.65 Mn |
| Sep 30, 2023 | -60.85 Mn |
| Sep 30, 2023 | -60.85 Mn |